Correlation Between GH Research and Mineralys Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GH Research and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GH Research PLC and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on GH Research and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and Mineralys Therapeutics,.

Diversification Opportunities for GH Research and Mineralys Therapeutics,

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between GHRS and Mineralys is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of GH Research i.e., GH Research and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between GH Research and Mineralys Therapeutics,

Given the investment horizon of 90 days GH Research PLC is expected to generate 3.53 times more return on investment than Mineralys Therapeutics,. However, GH Research is 3.53 times more volatile than Mineralys Therapeutics, Common. It trades about 0.07 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.1 per unit of risk. If you would invest  969.00  in GH Research PLC on December 1, 2024 and sell it today you would earn a total of  44.00  from holding GH Research PLC or generate 4.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GH Research PLC  vs.  Mineralys Therapeutics, Common

 Performance 
       Timeline  
GH Research PLC 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mineralys Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

GH Research and Mineralys Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GH Research and Mineralys Therapeutics,

The main advantage of trading using opposite GH Research and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.
The idea behind GH Research PLC and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities